caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1841459526

Madhavi YarlagaddaM.D.

EndocrinologyKansas City, MOI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
REFERRAL NETWORK

Where Madhavi Yarlagadda's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 21 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
MIDWEST DIVISION - RMC, LLC110494
Laboratory Corporation Of America
Clinical Laboratory · Dallas, TX
91246
CASS REGIONAL MEDICAL CENTER48179
MIDWEST DIVISION - RBH, LLC42123
Neil Bhargava
Diagnostic Radiology · Kansas City, MO
40146
Ahmad Al-Mubaslat
Endocrinology · Saint Joseph, MO
40668
Michael Farber
Diagnostic Radiology · Kansas City, MO
34237
Kiranmayi Chilappa
Cardiology · Kansas City, MO
21107
MIDWEST DIVISION - LSH, LLC1950
Cesar Rios
Internal Medicine · Kansas City, MO
19149
SAINT LUKES EAST HOSPITAL1732
Joe Cates
Vascular Surgery · Overland Park, KS
1794
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
499
Unique beneficiaries
—
Total services
785
Distinct HCPCS
7
Medicare payment
$47K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 144 Endocrinology providers in MO — below median (cohort median 929).
PRESCRIBING · PART D · 2024
Total Rx claims
2,225
Beneficiaries
—
Total drug cost
$818K
Distinct drugs
36
Brand share
52.2%
Top prescribed drugs
Levothyroxine Sodium258 claims
Glimepiride181 claims
Metformin Hcl159 claims
Semaglutide122 claims
Metformin Hcl101 claims
QUALITY · MIPS · 2024
Final MIPS score
24.7
Quality
16.3
Cost
66.2
Improvement activities
0.0
Promoting interop.
0.0
Payment adjustment
-6.03%
Group
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$16
Payment records
1
By payment type
Food and Beverage$16